Scarica l'app Stockscreener
12.36
2.18%
0.04
Precedente Chiudi:
$12.40
Aprire:
$12.4
Volume 24 ore:
25,548
Relative Volume:
0.14
Capitalizzazione di mercato:
$796.44M
Reddito:
-
Utile/perdita netta:
$-41.43M
Rapporto P/E:
-15.65
EPS:
-0.79
Flusso di cassa netto:
$-39.97M
1 W Prestazione:
+2.92%
1M Prestazione:
+8.29%
6M Prestazione:
+77.95%
1 anno Prestazione:
+5.67%
Intervallo 1D:
$12.36
$12.40
Intervallo di 1 settimana:
$11.50
$12.94
Portata 52W:
$6.00
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Confronta GHRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
12.36 | 796.44M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.34 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
525.72 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
316.65 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
558.20 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
GH Research announces annual general meeting for July 31 - Investing.com
GH Research Announces AGM and Key Resolutions for July 2025 - TipRanks
J Sainsbury plc (OTCMKTS:JSAIY) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Millennium Management LLC Acquires Shares of 20,761 GH Research PLC (NASDAQ:GHRS) - Defense World
GH Research to Participate in Neuro Perspectives Conference - TipRanks
Two Sigma Investments LP Makes New Investment in GH Research PLC (NASDAQ:GHRS) - Defense World
Cantor Fitzgerald Weighs in on GH Research FY2026 Earnings - Defense World
Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating - Insider Monkey
GH Research (NASDAQ:GHRS) Now Covered by Cantor Fitzgerald - Defense World
GHRS Stock Coverage Initiated with Positive Outlook | GHRS Stock News - GuruFocus
cantor fitzgerald maintains overweight rating on gh research stock By Investing.com - Investing.com Canada
cantor fitzgerald maintains overweight rating on gh research stock - Investing.com Australia
BNP Paribas Financial Markets Takes $44,000 Position in GH Research PLC (NASDAQ:GHRS) - Defense World
How To Trade (GHRS) - news.stocktradersdaily.com
Northern Trust Corp Has $286,000 Holdings in GH Research PLC (NASDAQ:GHRS) - Defense World
GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment - TipRanks
(GHRS) Long Term Investment Analysis - news.stocktradersdaily.com
GH Research to Present at ASCP Meeting on Depression Treatments - TipRanks
GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Beckley’s psychedelic reduces depression - BioWorld MedTech
GH Research (NASDAQ:GHRS) Upgraded at Cantor Fitzgerald - Defense World
GH Research (GHRS) Highlights Phase 2b Results at Clinical Confe - GuruFocus
GH Research (GHRS) Highlights Phase 2b Results at Clinical Conference | GHRS Stock News - GuruFocus
GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks
GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - Yahoo
GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World
Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World
GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus
GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus
GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating - TipRanks
GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Stock News - GuruFocus
Psychedelic: Compass, GH Research, MindMed report quarterly earnings - Yahoo Finance
GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus
GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks
GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq
GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan
What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance
Where are the Opportunities in (GHRS) - news.stocktradersdaily.com
Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News
Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World
What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister
Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine
(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(GHRS) Proactive Strategies - news.stocktradersdaily.com
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance
Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq
GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater
How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com
GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.37%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):